JP2024522304A5 - - Google Patents
Info
- Publication number
- JP2024522304A5 JP2024522304A5 JP2024518956A JP2024518956A JP2024522304A5 JP 2024522304 A5 JP2024522304 A5 JP 2024522304A5 JP 2024518956 A JP2024518956 A JP 2024518956A JP 2024518956 A JP2024518956 A JP 2024518956A JP 2024522304 A5 JP2024522304 A5 JP 2024522304A5
- Authority
- JP
- Japan
- Prior art keywords
- cancer
- alkyl
- compound according
- cancers
- formula
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163196744P | 2021-06-04 | 2021-06-04 | |
| US63/196,744 | 2021-06-04 | ||
| PCT/US2022/032203 WO2022256680A1 (en) | 2021-06-04 | 2022-06-03 | Pyridopyrimidine derivatives useful as wee1 kinase inhibitors |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024522304A JP2024522304A (ja) | 2024-06-13 |
| JP2024522304A5 true JP2024522304A5 (enExample) | 2025-06-10 |
Family
ID=82321319
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024518956A Pending JP2024522304A (ja) | 2021-06-04 | 2022-06-03 | Ｗｅｅ１キナーゼ阻害剤として有用なピリドピリミジン誘導体 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20240254123A1 (enExample) |
| EP (1) | EP4347592A1 (enExample) |
| JP (1) | JP2024522304A (enExample) |
| KR (1) | KR20240044409A (enExample) |
| CN (1) | CN117794932A (enExample) |
| AU (2) | AU2022287033B2 (enExample) |
| CA (1) | CA3225152A1 (enExample) |
| IL (1) | IL309037A (enExample) |
| MX (1) | MX2023014466A (enExample) |
| WO (1) | WO2022256680A1 (enExample) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA3253688A1 (en) | 2022-03-07 | 2023-09-14 | Debiopharm International S.A. | TREATMENT METHODS FOR SMALL CELL LUNG CANCER |
| WO2025056747A1 (en) | 2023-09-14 | 2025-03-20 | Debiopharm International S.A. | Combination of a wee1 inhibitor and a pkmyt1 inhibitor |
| CN120189510A (zh) * | 2023-12-21 | 2025-06-24 | 北京哲源科技有限责任公司 | 一种并环化合物的应用 |
| TW202541810A (zh) | 2023-12-22 | 2025-11-01 | 瑞士商德彪製藥國際公司 | 治療實體腫瘤之方法 |
| WO2025186213A1 (en) | 2024-03-04 | 2025-09-12 | Debiopharm International S.A. | Combination of a wee1 inhibitor and a topoisomerase 1 inhibitor |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2002250236A1 (en) | 2001-03-02 | 2002-09-19 | Medimmune, Inc. | Cd2 antagonists for treatment of autoimmune or inflammatory disease |
| PE20080695A1 (es) * | 2006-04-27 | 2008-06-28 | Banyu Pharma Co Ltd | Derivados de dihidropirazolopirimidinona como inhibidores de quinasa weel |
| MX2014010176A (es) * | 2012-02-23 | 2014-11-10 | Abbvie Inc | Inhibidores de cinasas de piridopirimidinona. |
| GB201306610D0 (en) * | 2013-04-11 | 2013-05-29 | Almac Discovery Ltd | Pharmaceutical compounds |
| GB201612095D0 (en) * | 2016-07-12 | 2016-08-24 | Almac Discovery Ltd | Pharmaceutical compounds |
| MX2020001235A (es) * | 2017-08-01 | 2020-07-20 | Recurium Ip Holdings Llc | Análogos de 1,2-dihidro-3h-pirazolo[3,4-d]pirimidin-3-ona. |
| GB201800378D0 (en) * | 2018-01-10 | 2018-02-21 | Almac Discovery Ltd | Pharmaceutical compounds |
-
2022
- 2022-06-03 CN CN202280054331.6A patent/CN117794932A/zh active Pending
- 2022-06-03 KR KR1020247000364A patent/KR20240044409A/ko active Pending
- 2022-06-03 IL IL309037A patent/IL309037A/en unknown
- 2022-06-03 EP EP22735735.7A patent/EP4347592A1/en active Pending
- 2022-06-03 JP JP2024518956A patent/JP2024522304A/ja active Pending
- 2022-06-03 AU AU2022287033A patent/AU2022287033B2/en active Active
- 2022-06-03 WO PCT/US2022/032203 patent/WO2022256680A1/en not_active Ceased
- 2022-06-03 US US18/565,598 patent/US20240254123A1/en active Pending
- 2022-06-03 CA CA3225152A patent/CA3225152A1/en active Pending
- 2022-06-03 MX MX2023014466A patent/MX2023014466A/es unknown
-
2025
- 2025-06-23 AU AU2025204724A patent/AU2025204724A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2024522304A5 (enExample) | ||
| IL309037A (en) | Pyridopyrimidine derivatives are useful as WEE1 kinase inhibitors | |
| ES2537352T3 (es) | Combinaciones de compuestos inhibidores de fosfoinositida 3-cinasa y agentes quimioterapéuticos, y metodos para su uso | |
| JP7014731B2 (ja) | 置換アミノプリン化合物、その組成物、及びそれらを用いた治療方法 | |
| CN120285177A (zh) | Hdac抑制剂和pd-1抑制剂的组合疗法 | |
| JP2015518894A5 (enExample) | ||
| JP6824906B2 (ja) | 併用療法 | |
| CN109819649B (zh) | 氨基嘌呤化合物的固体形式及其使用方法 | |
| KR20130069603A (ko) | 종양 및 섬유증 질환 치료에서의 신규 병용 치료 | |
| JP2018534289A5 (enExample) | ||
| CN112533602A (zh) | Axl激酶抑制剂及其用途 | |
| RU2014142057A (ru) | Комплексная терапия | |
| CN112043702A (zh) | 用于联合治疗结直肠癌的喹啉类化合物 | |
| CN112218639A (zh) | 包含双氟烷基-1,4-苯并二氮杂*酮化合物的组合组合物和其使用方法 | |
| JP2025061387A (ja) | 複素環式タンパク質キナーゼ阻害剤を含む製剤 | |
| CN112236147A (zh) | 包含双氟烷基-1,4-苯并二氮杂*酮化合物的组合物和其使用方法 | |
| EP3125901B1 (en) | Derivatives of cephalosporin for treating cancer | |
| CN114340636A (zh) | 治疗方法 | |
| CN106459011B (zh) | 作为抗肿瘤化合物的σ-2受体配体药物缀合物、其合成方法及其用途 | |
| CN112043831A (zh) | 用于联合治疗乳腺癌的喹啉类化合物 | |
| JP7636322B2 (ja) | 癌を処置するためのマドラシン誘導体化合物、組成物およびこれらの使用 | |
| JP2019516728A (ja) | 抗がん組合せ治療 | |
| EP3973963A1 (en) | Quinoline derivatives for treatment of head and neck cancer | |
| EP3310746A1 (en) | New crystalline polymorphs of 1,6-dibromo-1,6-dideoxy-dulcitol | |
| CN105392478A (zh) | 癌症化学疗法时的副作用降低剂 |